NMTRQ — 9 Meters Biopharma Balance Sheet
0.000.00%
Last trade - 00:00
FinancialsHighly SpeculativeMicro Cap
- $0.00m
- -$1.87m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 5.73 | 4.59 | 37.9 | 47 | 12.6 |
Net Total Receivables | 0 | — | — | — | — |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 6.41 | 5.22 | 38.9 | 50 | 33 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.035 | 0.068 | 0.226 | 0.183 | 0.123 |
Other Long Term Assets | |||||
Total Assets | 6.45 | 5.3 | 39.2 | 50.2 | 33.1 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 10.1 | 14.9 | 6.85 | 8.46 | 30.7 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 10.1 | 14.9 | 7.02 | 8.57 | 30.7 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -3.66 | -9.61 | 32.1 | 41.6 | 2.4 |
Total Liabilities & Shareholders' Equity | 6.45 | 5.3 | 39.2 | 50.2 | 33.1 |
Total Common Shares Outstanding |